Publications

343.
Nevo S., Frenkel N., Kadouri N. et al. (2024) Science Immunology. 9, 91, eabq6930.  Abstract [All authors]
342.
Tennenhouse A., Khmelnitsky L., Khalaila R. et al. (2024) Nature Biomedical Engineering. 8, p. 30-44  Abstract [All authors]
341.
Beumers L., Vlachavas E. I., Borgoni S. et al. (2023) NPJ Breast Cancer. 9, 1, 97.  Abstract [All authors]
340.
Gershoni A., Hassin O., Nataraj N. B. et al. (2023) Molecular Oncology. 17, 12, p. 2675-2693  Abstract [All authors]
339.
Marrocco I. & Yarden Y. (2023) Cancers. 15, 20, 5009.  Abstract
338.
Livneh I., Cohen-Kaplan V., Fabre B. et al. (2023) Molecular Cell. 83, 18, p. 3333-3346.e5  Abstract [All authors]
337.
Marrocco I., Giri S., Simoni-Nieves A. et al. (2023) Cell Reports Medicine. 4, 8, 101142.  Abstract [All authors]
336.
Lax E., Do Carmo S., Enuka Y. et al. (2023) Translational Psychiatry. 13, 1, 259.  Abstract [All authors]
335.
Hedegger K., Blutke A., Hommel T., Auer K. E., Nataraj N. B., Lindzen M., Yarden Y. & Dahlhoff M. (2023) Molecular Oncology.  Abstract
334.
Li X., Michels B. E., Tosun O. E. et al. (2022) Journal of Experimental and Clinical Cancer Research. 41, 1, 190.  Abstract [All authors]
333.
Aylon Y., Furth N., Mallel G. et al. (2022) Nature Communications. 13, 1, 7199.  Abstract [All authors]
332.
Noronha A., Belugali Nataraj N., Sang Lee J. et al. (2022) Cancer Discovery. 12, 11, p. 2666-2683  Abstract [All authors]
331.
Bergado-BáEz G., Gonzalez Suarez N., GarcíA L. C. et al. (2022) Frontiers in Oncology. 12,  Abstract [All authors]
330.
Hassin O., Nataraj N. B., Shreberk-Shaked M. et al. (2022) Nature Communications. 13, 1, 2800.  Abstract [All authors]
329.
Mukherjee S., Maddalena M., Lü Y. et al. (2022) Proceedings of the National Academy of Sciences. 119, 17, e211964411.  Abstract [All authors]
328.
Belugali Nataraj N., Noronha A., Lee J. S. et al. (2022) Cell Reports. 38, 8, 110418.  Abstract [All authors]
327.
Giacomelli C., Jung J., Wachter A. et al. (2021) BMC Cancer. 21, 1296.  Abstract [All authors]
326.
Singh A., Erijman A., Noronha A., Kumar H., Peleg Y., Yarden Y. & Shifman J. M. (2021) Journal of Biological Chemistry. 297, 6, 101353.  Abstract
325.
Shenoy A., Belugali Nataraj N., Perry G. et al. (2021) Molecular Systems Biology. 16, 9, e9443.  Abstract [All authors]
324.
Haga Y., Marrocco I., Noronha A. et al. (2021) Cancer Research. 81, 14, p. 3862-3875  Abstract [All authors]
323.
Nataraj N. B., Marrocco I. & Yarden Y. (2021) Biochemical Society Transactions. 49, 3, p. 1409-1423 BST2021004.  Abstract
322.
Brandao R., Kwa M. Q., Yarden Y. & Brakebusch C. (2021) FEBS Open Bio. 11, 6, p. 1579-1592  Abstract
321.
Uribe M. L., Marrocco I. & Yarden Y. (2021) Cancers. 13, 11, 2748.  Abstract
320.
Maddalena M., Mallel G., Nataraj N. B. et al. (2021) Proceedings of the National Academy of Sciences. 118, 23, e202563111.  Abstract [All authors]
319.
Lindzen M., Ghosh S., Noronha A. et al. (2021) Oncogene. 40, 21, p. 3665-3679  Abstract [All authors]
318.
Verduci L., Tarcitano E., Strano S., Yarden Y. & Blandino G. (2021) Cell Death & Disease. 12, 468.  Abstract
317.
Ghosh S., Nataraj N. B., Noronha A. et al. (2021) Cell Reports. 35, 8, 109181.  Abstract [All authors]
316.
Canu V., Donzelli S., Sacconi A. et al. (2021) Cell Death and Differentiation. 28, 5, p. 1493-1511  Abstract [All authors]
315.
Marrocco I., Romaniello D., Vaknin I. et al. (2021) EMBO Molecular Medicine. 13, 4, 13144.  Abstract [All authors]
314.
Su C., Zhang J., Yarden Y. & Fu L. (2021) Signal Transduction and Targeted Therapy. 6, 1, 109.  Abstract
313.
Yang C., Yang C., Yarden Y., To K. K. & Fu L. (2021) Drug Resistance Updates. 54, 100741.  Abstract
312.
Borgoni S., Sofyalı E., Soleimani M. et al. (2020) Cancers. 12, 10, 2918.  Abstract [All authors]
311.
Gaviraghi M., Rabellino A., Andolfo A. et al. (2020) Scientific Reports. 10, 16906.  Abstract [All authors]
310.
Romaniello D., Marrocco I., Nataraj N. B. et al. (2020) Cancers. 12, 9, 2394.  Abstract [All authors]
309.
Hoshino A., Kim H. S., Bojmar L. et al. (2020) Cell. 182, 4, p. 1044-1061.e18  Abstract [All authors]
308.
Wang X., Wang F., Zhong M., Yarden Y. & Fu L. (2020) Molecular Cancer. 19, 1, 81.  Abstract
307.
Mur E. B., Bernardo S., Papon L. et al. (2020) Journal of Clinical Investigation. 130, 2, p. 612-624  Abstract [All authors]
306.
Ghosh S., Marrocco I. & Yarden Y. (2020) Advances in Cancer Research. Fisher P. B. & Kumar R.(eds.). Vol. 147. p. 1-57  Abstract
305.
Srivastava S., Nataraj N. B., Sekar A. et al. (2019) Cell Reports. 29, 1, p. 104-117  Abstract [All authors]
304.
Maron R., Schechter B., Nataraj N. B. et al. (2019) Biochemical and Biophysical Research Communications. 513, 1, p. 219-225  Abstract
[All authors]
303.
Verduci L., Strano S., Yarden Y. & Blandino G. (2019) Molecular Oncology. 13, 4, p. 669-680  Abstract
302.
Kubli S. P., Bassi C., Roux C. et al. (2019) Proceedings of the National Academy of Sciences. 116, 9, p. 3604-3613  Abstract [All authors]
301.
Marrocco I., Romaniello D. & Yarden Y. (2019) Human Monoclonal Antibodies. Steinitz M. S.(eds.). p. 11-51  Abstract
300.
Romaniello D., Mazzeo L., Mancini M. et al. (2018) Clinical Cancer Research. 24, 22, p. 5610-5621  Abstract
[All authors]
299.
Gelfo V., Mazzeschi M., Grilli G. et al. (2018) Cancers. 10, 10, 355.  Abstract [All authors]
298.
Kreitman M., Noronha A. & Yarden Y. (2018) FEBS Letters. 592, 13, p. 2199-2212  Abstract
297.
Arandkar S., Furth N., Elisha Y. et al. (2018) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 115, 25, p. 6410-6415  Abstract [All authors]
296.
Claus J., Patel G., Autore F. et al. (2018) eLife. 7, 32271.  Abstract [All authors]
295.
Muti P., Donzelli S., Sacconi A. et al. (2018) Carcinogenesis. 39, 2, p. 98-108  Abstract [All authors]
294.
Mancini M., Gal H., Gaborit N. et al. (2018) EMBO Molecular Medicine. 10, 2, p. 294-308  Abstract [All authors]
293.
Roth L., Srivastava S., Lindzen M. et al. (2018) Science Signaling. 11, 515, 0949.  Abstract [All authors]
292.
Enuka Y., Feldman M. E., Chowdhury A. et al. (2017) Nucleic Acids Research. 45, 22, p. 12681–12699  Abstract [All authors]
291.
Dahlhoff M., Gaborit N., Bultmann S., Leonhardt H., Yarden Y. & Schneider M. R. (2017) FEBS Journal. 284, 19, p. 3339-3349  Abstract
290.
Savidor A., Barzilay R., Elinger D., Yarden Y., Lindzen M., Gabashvili A., Tal O. A. & Levin Y. (2017) Molecular & Cellular Proteomics. 16, 6, p. 1151-1161  Abstract
289.
Tarcic O., Granit R. Z., Pateras I. S. et al. (2017) Cell Death and Differentiation. 24, 4, p. 694-704  Abstract [All authors]
288.
Golan-Lavi R., Giacomelli C., Fuks G. et al. (2017) Cell Reports. 18, 13, p. 3129-3142  Abstract [All authors]
287.
Sas-Chen A., Srivastava S. & Yarden Y. (2017) Biochemical Society Transactions. 45, 1, p. 51-64  Abstract
286.
Golan T., Stossel C., Schvimer M. et al. (2017) Oncotarget. 8, 25, p. 40778-40790  Abstract [All authors]
285.
Gelfo V., Rodia M. T., Pucci M. et al. (2016) Oncotarget. 7, 44, p. 72167-72183  Abstract [All authors]
284.
Bublil E. M., Cohen T., Arnusch C. J., Peleg A., Pines G., Lavi S. & Yarden Y. (2016) Biochemistry. 55, 39, p. 5520-5530  Abstract
283.
Dittrich C., Kosty M., Jezdic S. et al. (2016) ESMO Open. 1, 5, e000097.  Abstract [All authors]
282.
Sas-Chen A., Aure M. R., Leibovich L. et al. (2016) EMBO Molecular Medicine. 8, 9, p. 1052-1064  Abstract
[All authors]
281.
Grossman M., Ben-Chetrit N., Zhuravlev A., Afik R., Bassat E., Solomonov I., Yarden Y. & Sagi I. (2016) Cancer Res.. 76, 14, 052206 .  Abstract
280.
Beyar-Katz O., Magidey K., Ben-Tsedek N. et al. (2016) Journal of Pathology. 239, 3, p. 262-273  Abstract [All authors]
279.
Schneider M. R. & Yarden Y. (2016) Oncogene. 35, 23, p. 2949-2960  Abstract
278.
Carvalho S., Levi-Schaffer F., Sela M. & Yarden Y. (2016) British Journal of Pharmacology. 173, 9, p. 1407-1424  Abstract
277.
Enuka Y., Lauriola M., Feldman M. E., Sas-Chen A., Ulitsky I. & Yarden Y. (2016) Nucleic Acids Research. 44, 3, p. 1370-1383  Abstract
276.
275.
Mancini M. & Yarden Y. (2016) Seminars in Cell & Developmental Biology. 50, p. 164-176  Abstract
274.
Donzelli S., Cioce M., Muti P., Strano S., Yarden Y. & Blandino G. (2016) Seminars in Cell & Developmental Biology. 50, p. 133-142  Abstract
273.
Gaborit N., Lindzen M. & Yarden Y. (2016) Human Vaccines & Immunotherapeutics. 12, 3, p. 576-592  Abstract
272.
Carvalho S., Lindzen M., Lauriola M. et al. (2016) Oncogene. 35, 4, p. 438-447  Abstract
[All authors]
271.
Toth G., Szoor A., Simon L., Yarden Y., Szollosi J. & Vereb G. (2016) mAbs. 8, 7, p. 1361-1370  Abstract
270.
Wilson S., Tod M., Ouerdani A. et al. (2015) CPT: Pharmacometrics and Systems Pharmacology. 4, 12, p. 720-727  Abstract
[All authors]
269.
Donzelli S., Mori F., Bellissimo T. et al. (2015) Oncotarget. 6, 34, p. 35183-35201  Abstract [All authors]
268.
Yarden Y. & Sela M. (2015) Clinical Cancer Research. 21, 18, p. 4030-4032  Abstract
267.
Capparelli C., Rosenbaum S., Berman-Booty L. D. et al. (2015) Cancer Research. 75, 17, p. 3554-3567  Abstract
[All authors]
266.
Rosenbaum S., Capparelli C., Berman-Booty L., Gaborit N., Zhan T., Davies M., Setiady Y., Yarden Y. & Aplin A. (2015) Molecular Cancer Therapeutics. 14, 7,  Abstract
265.
Mancini M., Gaborit N., Lindzen M., Salame T. M., Dall'Ora M., Sevilla-Sharon M., Abdul-Hai A., Downward J. & Yarden Y. (2015) Science Signaling. 8, 379, ra53.  Abstract
264.
D'Uva G., Aharonov A., Lauriola M. et al. (2015) Nature Cell Biology. 17, 5, p. 627-638  Abstract [All authors]
263.
Cohen-Dvashi H., Ben Chetrit C. N., Russell R. et al. (2015) EMBO Molecular Medicine. 7, 3, p. 299-314  Abstract
[All authors]
262.
Kedmi M., Ben Chetrit C. N., Koerner C. et al. (2015) Science Signaling. 8, 368, p. ra29  Abstract [All authors]
261.
Ben Chetrit C. N., Chetrit D., Russell R. et al. (2015) Science Signaling. 8, 360, ra7.  Abstract [All authors]
260.
Wheeler D. L. & Yarden Y. (2015)  Abstract
259.
Mahlknecht G., Sela M. & Yarden Y. (2015) Gene Therapy of Solid Cancers. p. 3-15  Abstract
258.
Wheeler D. L. & Yarden Y. (2015)  Abstract
257.
Gaborit N., Abdul-Hai A., Mancini M. et al. (2015) Proceedings of the National Academy of Sciences of the United States of America. 112, 3, p. 839-844  Abstract
[All authors]
256.
Muti P., Sacconi A., Hossain A. et al. (2014) Cancer Epidemiology Biomarkers & Prevention. 23, 11, p. 2471-2481  Abstract
[All authors]
255.
Blandino G., Fazi F., Donzelli S., Kedmi M., Sas-Chen A., Muti P., Strano S. & Yarden Y. (2014) FEBS Letters. 588, 16, p. 2639-2652  Abstract
254.
Kiuchi T., Ortiz-Zapater E., Monypenny J. et al. (2014) Science Signaling. 7, 339, ra78.  Abstract [All authors]
253.
Feldman M. E. & Yarden Y. (2014) FEBS Letters. 588, 15, p. 2407-2414  Abstract
252.
Bartsch R., Frings S., Marty M. et al. (2014) Annals of Oncology. 25, 4, p. 773-780  Abstract
[All authors]
251.
Schneider M. R. & Yarden Y. (2014) Seminars in Cell & Developmental Biology. 28, p. 57-61  Abstract
250.
Burgess A. W., Henis Y. I., Hynes N. E., Jovin T., Levitzki A., Pinkas-Kramarski R. & Yarden Y. (2014) Growth Factors. 32, 2, p. 74-81  Abstract
249.
Lauriola M., Enuka Y., Zeisel A. et al. (2014) Nature Communications. 5, 5073.  Abstract [All authors]
248.
HER
Kostler W. & Yarden Y. (2014) MOLECULAR ONCOLOGY: CAUSES OF CANCER AND TARGETS FOR TREATMENT. p. 85-109  Abstract
247.
Mellman I. & Yarden Y. (2013) Cold Spring Harbor perspectives in biology. 5, 12, a016949.  Abstract
246.
Koestler W. J., Zeisel A., Koerner C. et al. (2013) PLoS ONE. 8, 12, e80566.  Abstract
[All authors]
245.
D'Uva G., Bertoni S., Lauriola M. et al. (2013) PLoS ONE. 8, 11, e80742.  Abstract
[All authors]
244.
Maron R., Schechter B., Mancini M., Mahlknecht G., Yarden Y. & Sela M. (2013) Proceedings of the National Academy of Sciences of the United States of America. 110, 38, p. 15389-15394  Abstract
243.
Yarden Y. & Caldes C. (2013) European Journal of Cancer. 49, 12, p. 2619-2620  Abstract
242.
Biagioni F., Ben-Moshe N. B., Fontemaggi G., Yarden Y., Domany E. & Blandino G. (2013) Cell Cycle. 12, 15, p. 2371-2375  Abstract
241.
Mahlknecht G., Maron R., Mancini M., Schechter B., Sela M. & Yarden Y. (2013) Proceedings of the National Academy of Sciences of the United States of America. 110, 20, p. 8170-8175  Abstract
240.
Barnea I., Haif S., Keshet R. et al. (2013) Head And Neck-Journal For The Sciences And Specialties Of The Head And Neck. 35, 3, p. 399-407  Abstract
[All authors]
239.
Zeisel A., Yitzhaky A., Koerner C., Lauriola M., Cohen-Dvashi H., Koestler W. J., Yarden Y., Wiemann S. & Domany E. (2013) Journal of Biomolecular Screening. 18, 3, p. 356-360  Abstract
238.
Ben-Chetrit N., Tarcic G. & Yarden Y. (2013) Cell Adhesion & Migration. 7, 1, p. 33-37  Abstract
237.
Ferraro D. A., Gaborit N., Maron R. et al. (2013) Proceedings of the National Academy of Sciences of the United States of America. 110, 5, p. 1815-1820  Abstract [All authors]
236.
Biagioni F., Ben-Moshe N. B., Fontemaggi G. et al. (2012) EMBO Molecular Medicine. 4, 11, p. 1214-1229  Abstract [All authors]
235.
Ben-Moshe N. B., Avraham R., Kedmi M., Zeisel A., Yitzhaky A., Yarden Y. & Domany E. (2012) Nucleic Acids Research. 40, 21, p. 10614-10627  Abstract
234.
Pareja F., Ferraro D. A., Rubin C. et al. (2012) Oncogene. 31, 43, p. 4599-4608  Abstract [All authors]
233.
Yarden Y. & Pines G. (2012) Nature Reviews Cancer. 12, 8, p. 553-563  Abstract
232.
Pradeep C., Zeisel A., Koestler W. J. et al. (2012) Oncogene. 31, 31, p. 3569-3583  Abstract [All authors]
231.
Lindzen M., Carvalho S., Starr A. et al. (2012) Oncogene. 31, 30, p. 3505-3515  Abstract
[All authors]
230.
Tarcic G., Avraham R., Pines G. et al. (2012) FASEB Journal. 26, 4, p. 1582-1592  Abstract [All authors]
229.
Zwang Y., Oren M. & Yarden Y. (2012) Cancer Research. 72, 5, p. 1051-1054  Abstract
228.
Sas-Chen A., Avraham R. & Yarden Y. (2012) Journal of Mammary Gland Biology and Neoplasia. 17, 1, p. 3-14  Abstract
227.
Pradeep C., Koestler W. J., Lauriola M. et al. (2012) Oncogene. 31, 7, p. 907-917  Abstract [All authors]
226.
Avraham R. & Yarden Y. (2012) Biochemical Society Transactions. 40, 1, p. 26-30  Abstract
225.
Emde A., Mahlknecht G., Maslak K., Ribba B., Sela M., Possinger K. & Yarden Y. (2011) Translational Oncology. 4, 5, p. 293-300  Abstract
224.
Witsch E. J., Mahlknecht G., Wakim J., Sertchook R., Bublil E., Yarden Y. & Sela M. (2011) International Immunology. 23, 6, p. 391-403  Abstract
223.
Zwang Y., Sas-Chen A., Drier Y. et al. (2011) Molecular Cell. 42, 4, p. 524-535  Abstract [All authors]
222.
Emde A. M., Pradeep C., Ferraro D. A., Ben Chetrit C. N., Sela M., Ribba B., Kam Z. & Yarden Y. (2011) Oncogene. 30, 14, p. 1631-1642  Abstract
221.
Avraham R. & Yarden Y. (2011) Nature Reviews Molecular Cell Biology. 12, 2, p. 104-117  Abstract
220.
Yarden Y. (2011) Oncologist. 16 Suppl 1, p. 23-29  Abstract
219.
Zeisel A., Koestler W. J., Molotski N. et al. (2011) Molecular Systems Biology. 7, 529.  Abstract [All authors]
218.
Bublil E. M., Pines G., Patel G., Fruhwirth G., Ng T. & Yarden Y. (2010) FASEB Journal. 24, 12, p. 4744-4755  Abstract
217.
Pines G., Huang P. H., Zwang Y., White F. M. & Yarden Y. (2010) Oncogene. 29, 43, p. 5850-5860  Abstract
216.
Tarcic G. & Yarden Y. (2010) Map Kinase Signaling Protocols. Seger R.(eds.). Second Edition ed. p. 125-135 (trueMethods in Molecular Biology).  Abstract
215.
Lindzen M., Lavi S., Leitner O. & Yarden Y. (2010) Proceedings of the National Academy of Sciences of the United States of America. 107, 28, p. 12559-12563  Abstract
214.
Spangler J. B., Neil J. R., Abramovitch S., Yarden Y., White F. M., Lauffenburger D. A. & Wittrup K. D. (2010) Proceedings of the National Academy of Sciences of the United States of America. 107, 30, p. 13252-13257  Abstract
213.
Pines G., KöStler W. J. & Yarden Y. (2010) FEBS Letters. 584, 12, p. 2699-2706  Abstract
212.
The HER2 and EGFR alliance in cancer: defects in system control
Yarden Y. (2010) Ejc Supplements. 8, 5, p. 2-3  Abstract
211.
Witsch E., Sela M. & Yarden Y. (2010) Physiology. 25, 2, p. 85-101  Abstract
210.
Mills G. B. & Yarden Y. (2010) Cancer Cell. 17, 3, p. 217-218  Abstract
209.
Yarden Y. (2010) Oncologist. 15 Suppl 5, p. 1-7  Abstract
208.
KöStler W. J. & Yarden Y. (2010) Bortezomib in the Treatment of Multiple Myeloma. Bruinvels J. & Parnham M.(eds.). p. 1-32  Abstract
207.
Tarcic G., Boguslavsky S. K., Wakim J. et al. (2009) Current Biology. 19, 21, p. 1788-1798  Abstract [All authors]
206.
Yarden Y. (2009) New Biotechnology. 25, p. S15-S16  Abstract
205.
Mills G. B., Jurisica I., Yarden Y. & Norman J. C. (2009) Journal of Clinical Investigation. 119, 8, p. 2123-2127  Abstract
204.
Mosesson Y., Chetrit D., Schley L. et al. (2009) Developmental Cell. 16, 5, p. 687-698  Abstract
[All authors]
203.
Ben-Kasus T., Schechter B., Lavi S., Yarden Y. & Sela M. (2009) Proceedings of the National Academy of Sciences of the United States of America. 106, 9, p. 3294-3299  Abstract
202.
Mosesson Y., Mills G. B. & Yarden Y. (2009) Nature Reviews Cancer. 9, 2, p. 143  Abstract
201.
Mosesson Y., Mills G. B. & Yarden Y. (2008) Nature Reviews Cancer. 8, 11, p. 835-850  Abstract
200.
Yarden Y. (2008) Ejc Supplements. 6, 9, p. 1-1  Abstract
199.
Seger R., Rodeck U. & Yarden Y. (2008) IET Systems Biology. 2, 1, p. 1-4  Abstract
198.
Yarden Y. (2007) Ejc Supplements. 5, 9, p. 18-19  Abstract
197.
Yarden Y. & Shilo B. Z. (2007) Cell. 131, 5, p. 1018.e1-1018.e2  Abstract
196.
Shtiegman K., Kochupurakkal B. S., Zwang Y. et al. (2007) Oncogene. 26, 49, p. 6968-6978  Abstract
[All authors]
195.
Sundvall M., Peri L., Maatta J. A., Tvorogov D., Paatero I., Savisalo M., Silvennoinen O., Yarden Y. & Elenius K. (2007) Oncogene. 26, 48, p. 6905-6914  Abstract
194.
Yarden Y. & Amit I. (2007) Ejc Supplements. 5, 4, p. 44-44  Abstract
193.
Zwang Y. & Yarden Y. (2007) Ejc Supplements. 5, 5, p. 427-429  Abstract
192.
Katz M., Amit I. & Yarden Y. (2007) Biochimica et Biophysica Acta - Molecular Cell Research. 1773, 8, p. 1161-1176  Abstract
191.
Ben-Kasus T., Schechter B., Sela M. & Yarden Y. (2007) Molecular Oncology. 1, 1, p. 42-54  Abstract
190.
Spector N. L., Yarden Y., Smith B. et al. (2007) Proceedings of the National Academy of Sciences of the United States of America. 104, 25, p. 10607-10612  Abstract [All authors]
189.
Amit I., Citri A., Shay T. et al. (2007) Nature Genetics. 39, 4, p. 503-512  Abstract [All authors]
188.
Bublil E. M. & Yarden Y. (2007) Current Opinion in Cell Biology. 19, 2, p. 124-134  Abstract
187.
Amit I., Wides R. & Yarden Y. (2007) Molecular Systems Biology. 3, 151.  Abstract
186.
Zwang Y. & Yarden Y. (2006) EMBO Journal. 25, 18, p. 4195-4206  Abstract
185.
Germano S., Barberis D., Santoro M. M., Penengo L., Citri A., Yarden Y. & Gaudino G. (2006) Journal of Biological Chemistry. 281, 31, p. 21710-21719  Abstract
184.
Oved S., Mosesson Y., Zwang Y. et al. (2006) Journal of Biological Chemistry. 281, 31, p. 21640-21651  Abstract [All authors]
183.
Bacus S., Yarden Y., Xia W. & Spector N. L. (2006) Laboratory Medicine. 37, 8, p. 482-489  Abstract
182.
Citri A. & Yarden Y. (2006) Nature Reviews Molecular Cell Biology. 7, 7, p. 505-516  Abstract
181.
Starr A., Greif J., Vexler A. et al. (2006) International Journal of Cancer. 119, 2, p. 269-274  Abstract
[All authors]
180.
Li R., Soosairajah J., Harari D. et al. (2006) FASEB Journal. 20, 8, p. 1218-+  Abstract
[All authors]
179.
Citri A., Harari D., Shohat G. et al. (2006) Journal of Biological Chemistry. 281, 20, p. 14361-14369  Abstract [All authors]
178.
Monoubiquitylation: A recurrent theme in membrane protein transport
Mosesson Y. & Yarden Y. (2006) Israel Medical Association Journal. 8, 4, p. 233-237  Abstract
177.
Zsebik B., Citri A., Isola J., Yarden Y., Szollosi J. & Vereb G. (2006) Immunology Letters. 104, 1-2, p. 146-155  Abstract
176.
Sakaki Y., Kholodenko B., Hatakeyama M., Kitano H., Kolch W., De Meyts M. P., Yarden Y., Westerhoff H. & Wiley H. (2005) IET Systems Biology. 152, 2, p. 53-54  Abstract
175.
Kochupurakkal B., Harari D., Di-Segni A. et al. (2005) Journal of Biological Chemistry. 280, 9, p. 8503-8512  Abstract
[All authors]
174.
Rubin C., Zwang Y., Vaisman N., Ron D. & Yarden Y. (2005) Journal of Biological Chemistry. 280, 10, p. 9735-9744  Abstract
173.
Friedman L., Rinon A., Schechter B., Lyass L., Lavi S., Bacus S., Sela M. & Yarden Y. (2005) Proceedings of the National Academy of Sciences of the United States of America. 102, 6, p. 1915-1920  Abstract
172.
Kario E., Marmor M., Adamsky K., Citri A., Amit I., Amariglio N., Rechavi G. & Yarden Y. (2005) Journal of Biological Chemistry. 280, 8, p. 7038-7048  Abstract
171.
Rubin C., Gur G. & Yarden Y. (2005) Cell Research. 15, 1, p. 66-71  Abstract
170.
Citri A., Gan J., Mosesson Y., Vereb G., Szollosi J. & Yarden Y. (2004) EMBO Reports. 5, 12, p. 1165-1170  Abstract
169.
Bacus S., Spector N., Seger R. & Yarden Y. (2004) Journal of Immunotherapy. 27, 6, p. S57-S58  Abstract
168.
Yarden Y., Baselga J. & Miles D. (2004) Seminars in Oncology. 31, SUPPL. 10, p. 6-13  Abstract
167.
Mosesson Y. & Yarden Y. (2004) Seminars in Cancer Biology. 14, 4, p. 262-270  Abstract
166.
Gur G., Rubin C., Katz M. et al. (2004) EMBO Journal. 23, 16, p. 3270-3281  Abstract [All authors]
165.
Amit I., Yakir L., Katz M. et al. (2004) Genes & Development. 18, 14, p. 1737-1752  Abstract [All authors]
164.
Marmor M., Skaria K. & Yarden Y. (2004) International Journal of Radiation Oncology Biology Physics. 58, 3, p. 903-913  Abstract
163.
Marmor M. & Yarden Y. (2004) Oncogene. 23, 11 REV. ISS. 1, p. 2057-2070  Abstract
162.
Gur G. & Yarden Y. (2004) Nature biotechnology. 22, 2, p. 169-170  Abstract
161.
The achilles heel of ErbB-2/HER2: regulation by the Hsp90 chaperone machine and potential for pharmacological intervention.
Citri A., Kochupurakkal B. & Yarden Y. (2004) Cell cycle (Georgetown, Tex.). 3, 1, p. 51-60  Abstract
160.
Shelly M., Mosesson Y., Citri A., Lavi S., Zwang Y., Melamed-Book N., Aroeti B. & Yarden Y. (2003) Developmental Cell. 5, 3, p. 475-486  Abstract
159.
Penengo L., Rubin C., Yarden Y. & Gaudino G. (2003) Oncogene. 22, 24, p. 3669-3679  Abstract
158.
Mosesson Y., Shtiegman K., Katz M., Zwang Y., Vereb G., Szollosi J. & Yarden Y. (2003) Journal of Biological Chemistry. 278, 24, p. 21323-21326  Abstract
157.
Bao J., Gur G. & Yarden Y. (2003) Proceedings of the National Academy of Sciences of the United States of America. 100, 5, p. 2438-2443  Abstract
156.
Citri A., Skaria K. & Yarden Y. (2003) Experimental Cell Research. 284, 1, p. 54-65  Abstract
155.
Shtiegman K. & Yarden Y. (2003) Seminars in Cancer Biology. 13, 1, p. 29-40  Abstract
154.
Rubin C., Litvak V., Medvedovsky H., Zwang Y., Lev S. & Yarden Y. (2003) Current Biology. 13, 4, p. 297-307  Abstract
153.
Huotari M. A., Miettinen P. J., Palgi J., Koivisto T., Ustinov J., Harari D., Yarden Y. & Otonkoski T. (2002) Endocrinology. 143, 11, p. 4437-4446  Abstract
152.
Katz M., Shtiegman K., Tal-Or P. et al. (2002) Traffic. 3, 10, p. 740-751  Abstract
[All authors]
151.
Citri A., Alroy I., Lavi S. et al. (2002) EMBO Journal. 21, 10, p. 2407-2417  Abstract
[All authors]
150.
Yarden Y. (2002) European Journal of Cancer. 38, p. S48-S48  Abstract
149.
Oved S. & Yarden Y. (2002) Nature. 416, 6877, p. 133-136  Abstract
148.
Waterman H., Katz M., Rubin C., Shtiegman K., Lavi S., Elson A., Jovin T. & Yarden Y. (2002) EMBO Journal. 21, 3, p. 303-313  Abstract
147.
Ettenberg S., Magnifico A., Cuello M., Nau M., Rubinstein Y., Yarden Y., Weissman A. & Lipkowitz S. (2001) Journal of Biological Chemistry. 276, 29, p. 27677-27684  Abstract
146.
Waterman H. & Yarden Y. (2001) FEBS Letters. 490, 3, p. 142-152  Abstract
145.
Yarden Y. & Sliwkowski M. (2001) Nature Reviews Molecular Cell Biology. 2, 2, p. 127-137  Abstract
144.
Xu W., Mimnaugh E., Rosser M. F., Nicchitta C., Marcu M., Yarden Y. & Neckers L. (2001) Journal of Biological Chemistry. 276, 5, p. 3702-3708  Abstract
143.
Yarden Y. (2001) European Journal of Cancer. 37, SUPPL. 4, p. 3-8  Abstract
142.
Bacus S., Gudkov A., Lowe M., Lyass L., Yung Y., Komarov A., Keyomarsi K., Yarden Y. & Seger R. (2001) Oncogene. 20, 2, p. 147-155  Abstract
141.
Yarden Y. (2001) Oncology. 61, SUPPL. 2, p. 1-13  Abstract
140.
Rubin I. & Yarden Y. (2001) Annals of Oncology. 12, SUPPL. 1, p. S3-S8  Abstract
139.
Vaisman N., Nissim A., Klapper L., Tirosh B., Yarden Y. & Sela M. (2000) Immunology Letters. 75, 1, p. 61-67  Abstract
138.
Harari D. & Yarden Y. (2000) Oncogene. 19, 53, p. 6102-6114  Abstract
137.
Levkowitz G., Oved S., Klapper L., Harari D., Lavi S., Sela M. & Yarden Y. (2000) Journal of Biological Chemistry. 275, 45, p. 35532-35539  Abstract
136.
Bao J., Alroy I., Waterman H., Schejter E., Brodie C., Gruenberg J. & Yarden Y. (2000) Journal of Biological Chemistry. 275, 34, p. 26178-26186  Abstract
135.
Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2
Klapper L. N., Waterman H., Sela M. & Yarden Y. (2000) Cancer Research. 60, 13, p. 3384-3388  Abstract
134.
Supino-Rosin L., Yoshimura A., Yarden Y., Elazar Z. & Neumann D. (2000) Journal of Biological Chemistry. 275, 29, p. 21850-21855  Abstract
133.
Zhu Z., Kleeff J., Friess H., Wang L., Zimmermann A., Yarden Y., Buchler M. & Korc M. (2000) Biochemical and Biophysical Research Communications. 273, 3, p. 1019-1024  Abstract
132.
Chausovsky A., Waterman H., Elbaum M., Yarden Y., Geiger B. & Bershadsky A. (2000) Oncogene. 19, 7, p. 878-888  Abstract
131.
Lee R., Albanese C., Fu M. et al. (2000) Molecular and Cellular Biology. 20, 2, p. 672-683  Abstract [All authors]
130.
Kirschbaum M. H. & Yarden Y. (2000) Journal of Cellular Biochemistry. 77, SUPPL. 34, p. 52-60  Abstract
129.
Hurwitz E., Klapper L., Wilchek M., Yarden Y. & Sela M. (2000) Cancer Immunology Immunotherapy. 49, 4-5, p. 226-234  Abstract
128.
Levkowitz G., Waterman H., Ettenberg S. et al. (1999) Molecular Cell. 4, 6, p. 1029-1040  Abstract [All authors]
127.
Yarden Y. (1999) European Journal of Cancer. 35, p. S133-S133  Abstract
126.
Waterman H., Levkowitz G., Alroy I. & Yarden Y. (1999) Journal of Biological Chemistry. 274, 32, p. 22151-22154  Abstract
125.
Soussan L., Burakov D., Daniels M., Toister-Achituv M., Porat A., Yarden Y. & Elazar Z. (1999) Journal of Cell Biology. 146, 2, p. 301-311  Abstract
124.
Brizzi M., Dentelli P., Rosso A., Yarden Y. & Pegoraro L. (1999) Journal of Biological Chemistry. 274, 24, p. 16965-16972  Abstract
123.
Waterman H., Alroy I., Strano S., Seger R. & Yarden Y. (1999) EMBO Journal. 18, 12, p. 3348-3358  Abstract
122.
Harari D., Tzahar E., Romano J., Shelly M., Pierce J. H., Andrews G. C. & Yarden Y. (1999) Oncogene. 18, 17, p. 2681-2689  Abstract
121.
Klapper L., Glathe S., Vaisman N., Hynes N., Andrews G., Sela M. & Yarden Y. (1999) Proceedings of the National Academy of Sciences of the United States of America. 96, 9, p. 4995-5000  Abstract
120.
Alroy I., Soussan L., Seger R. & Yarden Y. (1999) Molecular and Cellular Biology. 19, 3, p. 1961-1972  Abstract
119.
Klapper L. N., Kirschbaum L. N., Sela M. & Yarden Y. (1999) Advances in Cancer Research. 77, p. 25-79  Abstract
118.
Signal transduction by growth factors: Information transfer and processing by biological networks
Alroy I. & Yarden Y. (1999) Molecular Mechanisms Of Transcellular Signaling: From Membrane Receptors To Transcription Factors. 309, p. 142-166  Abstract
117.
Levkowitz G., Waterman H., Zamir E., Kam Z., Oved S., Langdon W., Beguinot L., Geiger B. & Yarden Y. (1998) Genes & Development. 12, 23, p. 3663-3674  Abstract
116.
Chausovsky A., Tsarfaty I., Kam Z., Yarden Y., Geiger B. & Bershadsky A. (1998) Molecular Biology of the Cell. 9, 11, p. 3195-3209  Abstract
115.
Tzahar E., Moyer J., Waterman H. et al. (1998) EMBO Journal. 17, 20, p. 5948-5963  Abstract
[All authors]
113.
Lenferink A., Pinkas-Kramarski R., Van De Poll D. P. M. et al. (1998) EMBO Journal. 17, 12, p. 3385-3397  Abstract
[All authors]
112.
Waterman H., Sabanai I., Geiger B. & Yarden Y. (1998) Journal of Biological Chemistry. 273, 22, p. 13819-13827  Abstract
111.
Pinkas-Kramarski R., Lenferink A., Bacus S. et al. (1998) Oncogene. 16, 10, p. 1249-1258  Abstract [All authors]
110.
Zrihan-Licht S., Deng B., Yarden Y., Mcshan G., Keydar I. & Avraham H. (1998) Journal of Biological Chemistry. 273, 7, p. 4065-4072  Abstract
109.
Eilam R., Pinkas-Kramarski R., Ratzkin B., Segal M. & Yarden Y. (1998) Proceedings of the National Academy of Sciences of the United States of America. 95, 4, p. 1888-1893  Abstract
108.
Tzahar E. & Yarden Y. (1998) Biochimica Et Biophysica Acta-Reviews On Cancer. 1377, 1, p. M25-M37  Abstract
107.
Pinkas-Kramarski R., Shelly M., Guarino B. et al. (1998) Molecular and Cellular Biology. 18, 10, p. 6090-6101  Abstract [All authors]
106.
Tzahar E., Pinkaskramarski R., Moyer J. et al. (1997) EMBO Journal. 16, 16, p. 4938-4950  Abstract
[All authors]
104.
Alroy I. & Yarden Y. (1997) FEBS Letters. 410, 1, p. 83-86  Abstract
103.
Pinkas-Kramarski R., Alroy I. & Yarden Y. (1997) Journal of Mammary Gland Biology and Neoplasia. 2, 2, p. 97-107  Abstract
102.
Pinkaskramarski R., Eilam R., Alroy I., Levkowitz G., Lonai P. & Yarden Y. (1997) Oncogene. 15, 23, p. 2803-2815  Abstract
101.
Klapper L., Vaisman N., Hurwitz E., Pinkaskramarski R., Yarden Y. & Sela M. (1997) Oncogene. 14, 17, p. 2099-2109  Abstract
100.
Kristt D. A. & Yarden Y. (1996) Cancer. 78, 6, p. 1272-1283  Abstract
99.
Pinkaskramarski R., Soussan L., Waterman H. et al. (1996) EMBO Journal. 15, 10, p. 2452-2467  Abstract [All authors]
98.
Chen X., Levkowitz G., Tzahar E. et al. (1996) Journal of Biological Chemistry. 271, 13, p. 7620-7629  Abstract
[All authors]
97.
Mincione G., Bianco C., Kannan S. et al. (1996) Journal of Cellular Biochemistry. 60, 4, p. 437-446  Abstract
[All authors]
96.
Brizzi M., Aronica M., Rosso A., Bagnara G., Yarden Y. & Pegoraro L. (1996) Journal of Biological Chemistry. 271, 7, p. 3562-3567  Abstract
95.
Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors
Bacus S., Chin D., Yarden Y., Zelnick C. & Stern D. (1996) American Journal of Pathology. 148, 2, p. 549-558  Abstract
94.
Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells
Bacus S., Yarden Y., Oren M. et al. (1996) Oncogene. 12, 12, p. 2535-2547  Abstract
[All authors]
93.
Goren D., Horowitz A., Zalipsky S., Woodle M., Yarden Y. & Gabizon A. (1996) British Journal of Cancer. 74, 11, p. 1749-1756  Abstract
92.
Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins
Levkowitz G., Klapper L. N., Tzahar E., Freywald A., Sela M. & Yarden Y. (1996) Oncogene. 12, 5, p. 1117-1125  Abstract
91.
Tzahar E., Waterman H., Chen X., Levkowitz G., Karunagaran D., Lavi S., Ratzkin B. & Yarden Y. (1996) Molecular and Cellular Biology. 16, 10, p. 5276-5287  Abstract
90.
Pinkaskramarski R., Shelly M., Glathe S., Ratzkin B. & Yarden Y. (1996) Journal of Biological Chemistry. 271, 32, p. 19029-19032  Abstract
89.
Karunagaran D., Tzahar E., Beerli R., Chen X., Graus-Porta D., Ratzkin B., Seger R., Hynes N. & Yarden Y. (1996) EMBO Journal. 15, 2, p. 254-264  Abstract
88.
p91 STAT1 activation in interleukin-3-stimulated primary acute myeloid leukemia cells
Aronica M., Brizzi M., Dentelli P., Rosso A., Yarden Y. & Pegoraro L. (1996) Oncogene. 13, 5, p. 1017-1026  Abstract
87.
Schleef M., Simon-Chazottes D., Lengeling A., Klocke R., Jockusch H., Yarden Y. & GuéNet J. L. (1996) Mammalian Genome. 7, 10, p. 788  Abstract
86.
Beerli R., Grausporta D., Woodscook K., Chen X., Yarden Y. & Hynes N. (1995) Molecular and Cellular Biology. 15, 12, p. 6496-6505  Abstract
85.
Dong Z., Brennan A., Liu N., Yarden Y., Levkowitz G., Mirsky R. & Jessen K. (1995) Neuron. 15, 3, p. 585-596  Abstract
84.
Blechman J. M. & Yarden Y. (1995) Annals of the New York Academy of Sciences. 766, 1, p. 344-362  Abstract
83.
ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes
Marikovsky M., Lavi S., Pinkaskramarski R., Karunagaran D., Liu N., Wen D. & Yarden Y. (1995) Oncogene. 10, 7, p. 1403-1411  Abstract
82.
Hurwitz E., Stancovski I., Sela M. & Yarden Y. (1995) Proceedings of the National Academy of Sciences of the United States of America. 92, 8, p. 3353-3357  Abstract
81.
Gilboa L., Benlevy R., Yarden Y. & Henis Y. (1995) Journal of Biological Chemistry. 270, 13, p. 7061-7067  Abstract
80.
Lu H., Chang D., Philo J. et al. (1995) Journal of Biological Chemistry. 270, 9, p. 4784-4791  Abstract
[All authors]
79.
Migdal M., Soker S., Yarden Y. & Neufeld G. (1995) Journal of Cellular Physiology. 162, 2, p. 266-276  Abstract
78.
Karunagaran D., Tzahar E., Liu N., Wen D. & Yarden Y. (1995) Journal of Biological Chemistry. 270, 17, p. 9982-9990  Abstract
77.
Marte B., Jeschke M., Grausporta D., Taverna D., Hofer P., Groner B., Yarden Y. & Hynes N. (1995) Molecular Endocrinology. 9, 1, p. 14-23  Abstract
76.
Blechman J., Lev S., Barg J., Eisenstein M., Vaks B., Vogel Z., Givol D. & Yarden Y. (1995) Cell. 80, 1, p. 103-113  Abstract
75.
Convergence of signaling by interleukin-3, granulocyte-macrophage colony-stimulating factor, and mast cell growth factor on JAK2 tyrosine kinase
Brizzi M. F., Zini M. G., Aronica M. G., Blechman J. M., Yarden Y. & Pegoraro L. (1994) Journal of Biological Chemistry. 269, 50, p. 31680-31684  Abstract
74.
Medullary carcinoma is associated with expression of intercellular adhesion molecule-1: Implication to its morphology and its clinical behavior
Bacus S., Zelnick C., Chin D., Yarden Y., Kaminsky D., Bennington J., Wen D., Marcus J. & Page D. (1994) American Journal of Pathology. 145, 6, p. 1337-1348  Abstract
73.
Tzahar E., Levkowitz G., Karunagaran D. et al. (1994) Journal of Biological Chemistry. 269, 40, p. 25226-25233  Abstract
[All authors]
72.
Pinkaskramarski R., Eilam R., Spiegler O., Lavi S., Liu N., Chang D., Wen D., Schwartz M. & Yarden Y. (1994) Proceedings of the National Academy of Sciences of the United States of America. 91, 20, p. 9387-9391  Abstract
71.
Adelaide J., Penaultllorca F., Dib A., Yarden Y., Jacquemier J. & Birnbaum D. (1994) Genes Chromosomes & Cancer. 11, 1, p. 66-69  Abstract
70.
Benbaruch N. & Yarden Y. (1994) Proceedings Of The Society For Experimental Biology And Medicine. 206, 3, p. 221-227  Abstract
69.
Protein kinase C-dependcnt release of a functional whole extracellular domain of the mast cell growth factor (MGF) receptor by MGF-dependent human myeloid cells
Brizzi M. F., Blechman J. M., Cavalloni G., Givol D., Yarden Y. & Pegoraro L. (1994) Oncogene. 9, 6, p. 1583-1589  Abstract
68.
Wen D., Suggs S., Karunagaran D. et al. (1994) Molecular and Cellular Biology. 14, 3, p. 1909-1919  Abstract
[All authors]
67.
Stancovski I., Sela M. & Yarden Y. (1994) Mammary Tumorigenesis and Malignant Progression. Boston, MA: . Vol. 71. p. 161-191 (trueCancer Treatment and Research).  Abstract
66.
Expression of the erbB-2 family of growth factor receptors and their ligands in breast cancers: Implication for tumor biology and clinical behavior
Bacus S., Zelnick C., Plowman G. & Yarden Y. (1994) American Journal of Clinical Pathology. 102, 4 SUPPL. 1, p. S13-S24  Abstract
65.
Bartley T. D., Hunt R. W., Welcher A. A. et al. (1994) Nature. 368, 6471, p. 558-560  Abstract [All authors]
64.
Ben-Levy R., Paterson H., Marshall C. & Yarden Y. (1994) EMBO Journal. 13, 14, p. 3302-3311  Abstract
63.
Lev S., Blechman J. M., Givol D. & Yarden Y. (1994) Critical Reviews in Oncogenesis. 5, 2-3, p. 141-168  Abstract
62.
Peles E. & Yarden Y. (1993) BioEssays. 15, 12, p. 815-824  Abstract
61.
Targeting of T Lymphocytes to Neu/HER2-Expressing Cells Using Chimeric Single Chain Fv Receptors
Stancovski I., Schindler D., Waks T., Yarden Y., Sela M. & Eshhar Z. (1993) Journal of Immunology. 151, 11, p. 6577-6582  Abstract
60.
KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells
Zakut R., Perlis R., Eliyahu S., Yarden Y., Givol D., Lyman S. & Halaban R. (1993) Oncogene. 8, 8, p. 2221-2229  Abstract
59.
Kristt D. A., Reedy E. & Yarden Y. (1993) Neurosurgery. 33, 1, p. 106-115  Abstract
58.
Blechman J. M., Lev S., Givol D. & Yarden Y. (1993) Stem Cells. 11, 2 S, p. 12-21  Abstract
57.
Halaban R., Tyrrell L., Longley J., Yarden Y. & Rubin J. (1993) Annals of the New York Academy of Sciences. 680, 1, p. 290-301  Abstract
56.
Lev S., Blechman J., Nishikawa S. I., Givol D. & Yarden Y. (1993) Molecular and Cellular Biology. 13, 4, p. 2224-2234  Abstract
55.
Peles E., Ben-Levy R., Tzahar E., Liu N., Wen D. & Yarden Y. (1993) EMBO Journal. 12, 3, p. 961-971  Abstract
54.
Orrurtreger A., Trakhtenbrot L., Benlevy R., Wen D., Rechavi G., Lonai P. & Yarden Y. (1993) Proceedings of the National Academy of Sciences of the United States of America. 90, 5, p. 1867-1871  Abstract
53.
Blechman J. M., Lev S., Brizzi M. F., Leitner O., Pegoraro L., Givol D. & Yarden Y. (1993) Journal of Biological Chemistry. 268, 6, p. 4399-4406  Abstract
52.
Bacus S. S., Gudkov A. V., Zelnick C. R. et al. (1993) Cancer Research. 53, 21, p. 5251-5261  Abstract
[All authors]
51.
The murine vik gene (chromosome 9) encodes a putative receptor with unique protein kinase motifs
Kelman Z., Simon-Chazottes D., GuéNet J. L. & Yarden Y. (1993) Oncogene. 8, 1, p. 37-44  Abstract
50.
Expression of amphiregulin, cripto-1, and heregulin α in human breast cancer cells
Normanno N., Qi C., Gullick W. et al. (1993) International Journal of Oncology. 2, 6, p. 903-911  Abstract [All authors]
49.
Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3′-kinase upon its association with pp185 (IRS-1) in intact rat livers
Hadari Y. R., Tzahar E., Nadiv O., Rothenberg P., Roberts C. T., Leroith D., Yarden Y. & Zick Y. (1992) Journal of Biological Chemistry. 267, 25, p. 17483-17486  Abstract
48.
An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity: Implications for the generation of site heterogeneity
Ben-Levy R., Peles E., Goldman-Michael R. & Yarden Y. (1992) Journal of Biological Chemistry. 267, 24, p. 17304-17313  Abstract
47.
Structural organization of the murine c-kit proto-oncogene
Gokkel E., Grossman Z., Ramot B., Yarden Y., Rechavi G. & Givoli D. (1992) Oncogene. 7, 7, p. 1423-1429  Abstract
46.
Regulated coupling of the Neu receptor to phosphatidylinositol 3′-kinase and its release by oncogenic activation
Peles E., Lamprecht R., Benlevy R., Tzahar E. & Yarden Y. (1992) Journal of Biological Chemistry. 267, 17, p. 12266-12274  Abstract
45.
Wen D., Peles E., Cupples R. et al. (1992) Cell. 69, 3, p. 559-572  Abstract
[All authors]
44.
Bacus S. S., Stancovski I., Huberman E., Chin D., Hurwitz E., Mills G. B., Ullrich A., Sela M. & Yarden Y. (1992) Cancer Research. 52, 9, p. 2580-2589  Abstract
43.
Lev S., Yarden Y. & Givol D. (1992) Journal of Biological Chemistry. 267, 15, p. 10866-10873  Abstract
42.
Peles E., Bacus S., Koski R., Lu H., Wen D., Ogden S., Benlevy R. & Yarden Y. (1992) Cell. 69, 1, p. 205-216  Abstract
41.
Hemmerich S., Yarden Y. & Pecht I. (1992) Biochemistry. 31, 19, p. 4574-4579  Abstract
40.
C-kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas
Funasaka Y., Boulton T., Cobb M. et al. (1992) Molecular Biology of the Cell. 3, 2, p. 197-209  Abstract
[All authors]
39.
Geiger B., Ayalon O., Ginsberg D., Volberg T., Fernandez J., Yarden Y. & Ben-Ze'Ev A. (1992) Cold Spring Harbor Symposia on Quantitative Biology. 57, p. 631-642  Abstract
38.
Lev S., Yarden Y. & Givol D. (1992) Journal of Biological Chemistry. 267, 22, p. 15970-15977  Abstract
37.
Lev S., Givol D. & Yarden Y. (1992) Proceedings of the National Academy of Sciences of the United States of America. 89, 2, p. 678-682  Abstract
36.
Developmental expression of two murine fibroblast growth factor receptors, flg and bek
Orrurtreger A., Givol D., Yayon A., Yarden Y. & Lonai P. (1991) Development. 113, 4, p. 1419-1434  Abstract
35.